Efficacy and Safety of Tofacitinib in the Treatment of Refractory Chronic Spontaneous Urticaria: A Real-World Study
Published: 22 August 2026| Version 1 | DOI: 10.17632/jtmws9wskf.1
Contributor:
anqi chenDescription
The set of supplemental materials support the JAAD manuscript “Efficacy and Safety of Tofacitinib in the Treatment of Refractory Chronic Spontaneous Urticaria: A Real-World Study” supplementary Table 1. Comparison of demographic characteristics between responders and non-responders to tofacitinib. supplementary Table 2. Comparison of laboratory findings between responders and non-responders to tofacitinib. supplementary Figure 1. ROC curve analvsis of BLR and Lymph for predicting response to tofacitinib in refractory CSU.
Files
Institutions
- Army Medical UniversityChongqing, Chongqing
Categories
Urticaria